NCT04524000 2026-01-12
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer
Novartis
Phase 2 Active not recruiting
Novartis
RenJi Hospital
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Seoul National University Hospital